Sun Pharma share price falls 2% after Q4 Results

[{"selector":"#anim-00235de3-9c1f-405a-8d55-02672a892bf3","keyframes":{"opacity":[0,1]},"delay":0,"duration":3000,"easing":"cubic-bezier(0.2, 0.6, 0.0, 1)","fill":"both"}] [{"selector":"#anim-cf7c58a0-bf9a-4f4c-b061-b53dbb1a9011","keyframes":{"transform":["translate3d(0px, 100.04883%, 0)","translate3d(0px, 0px, 0)"]},"delay":0,"duration":3000,"easing":"cubic-bezier(0.2, 0.6, 0.0, 1)","fill":"both"}] [{"selector":"#anim-e06b8652-b6c9-42d8-a5ce-a6f03ee7162f","keyframes":{"opacity":[0,1]},"delay":0,"duration":1500,"easing":"cubic-bezier(0.2, 0.6, 0.0, 1)","fill":"both"}] [{"selector":"#anim-87254d19-f28e-4a7a-a1f1-2f0fc7bb2f45","keyframes":{"transform":["translate3d(0px, 505.68682%, 0)","translate3d(0px, 0px, 0)"]},"delay":0,"duration":1500,"easing":"cubic-bezier(0.2, 0.6, 0.0, 1)","fill":"both"}]

[{"selector":"#anim-43368c7f-6b6d-4c67-b6a0-f17a5b79029b","keyframes":{"opacity":[1,1]},"delay":0,"duration":2000,"easing":"cubic-bezier(.3,0,.55,1)","fill":"both"}] [{"selector":"#anim-6f8aa659-2cb2-4d3c-8c87-f1a20dd950d1","keyframes":{"transform":["scale(3)","scale(1)"]},"delay":0,"duration":2000,"easing":"cubic-bezier(.3,0,.55,1)","fill":"forwards"}] Sun Pharmaceuticals' share price fell 2% to Rs 856.7 on the NSE on Tuesday after the drugmaker reported a surprise net loss of Rs 2,227.38 crore for the quarter ended March 2022.

[{"selector":"#anim-14853f5b-f7a9-4ab0-b53a-e043c417b2fa","keyframes":{"opacity":[0,1]},"delay":0,"duration":2000,"easing":"cubic-bezier(.3,0,.55,1)","fill":"both"}] [{"selector":"#anim-85da5aef-0777-4861-85d6-8a7cd2a0a159","keyframes":{"transform":["scale(0.3333333333333333)","scale(1)"]},"delay":0,"duration":2000,"easing":"cubic-bezier(.3,0,.55,1)","fill":"forwards"}] Revenue for the quarter increased 11% year on year to Rs 9,386.08 crore.

[{"selector":"#anim-eab553c6-5fb1-438d-9781-3020d929e2a1 [data-leaf-element=\"true\"]","keyframes":{"transform":["translate(0%, 0%) scale(1.5)","translate(0%, 0%) scale(1)"]},"delay":0,"duration":2000,"easing":"cubic-bezier(.3,0,.55,1)","fill":"forwards"}] Dilip Shanghvi was also reappointed as managing director for another five-year term, and Pawan Goenka was named lead independent director.

[{"selector":"#anim-47991211-4054-4a5d-bd4d-7b8c636773ec","keyframes":{"opacity":[0,1]},"delay":0,"duration":2000,"easing":"cubic-bezier(.3,0,.55,1)","fill":"both"}] [{"selector":"#anim-f00c5de8-50b7-412c-aecf-696347d3984c","keyframes":{"transform":["scale(0.3333333333333333)","scale(1)"]},"delay":0,"duration":2000,"easing":"cubic-bezier(.3,0,.55,1)","fill":"forwards"}] Sun Pharma stock has outperformed benchmarks so far this year.

Sun Pharma delivered a lower-than-expected 4QFY22 result due to moderation in the RoW/EMs/API segment and higher OPEX, according to analysts at Motilal Oswal Financial Services.